Jana L. Kolarik

Partner

Jana Kolarik’s deep understanding and unique experience with Federal and State health care regulatory requirements, Anti-Kickback Statute risks, and Stark Law issues helps clients further safeguard their arrangements in the health care and life sciences sector.

Clients trust Jana to recommend compliance strategies to manage risk, including –

  • advising on compliant compensation and ownership models,
  • working with client to address coding, coverage and payment issues affecting claims and repayment obligations,
  • structuring corporate compliance effectiveness reviews and implementing compliance program changes,
  • providing health care regulatory due diligence advice on transactions, and
  • assisting on Office of Inspector (OIG) and Centers for Medicare & Medicaid Services (CMS) voluntary self-disclosures.

She has also served as a Compliance Expert and Legal Independent Review Organization (IRO) for different OIG Corporate Integrity Agreements (CIAs).

Jana represents a broad range of organizations in the health care and life sciences sector, which includes health systems, hospitals, physician groups, home medical equipment suppliers and device manufacturers, as well as investors in health care entities. Jana is a member of the firm’s Health Care Practice Group and Government Enforcement, Defense & Investigations Practice Group.

Representative Experience

  • Counsels in-house counsel, compliance officers and executive teams on structuring compliance programs and addressing health care compliance issues (e.g., fraud and abuse-related, licensure, claims-related).
  • Counsels clients on how to structure compensation and ownership arrangements in compliance with the Anti-Kickback Statute and Stark Law.
  • Structures corporate compliance effectiveness reviews and advises on recommended compliance program implementation and changes.
  • Advises on claims-related issues including statistical sampling, extrapolation and repayment recommendations for providers and suppliers.
  • Assists on OIG and CMS voluntary self-disclosures.
  • Counsels clients on compliance with coding, coverage and payment rules.
  • Acts as Compliance Expert for a clinical laboratory pursuant to its OIG CIA.
  • Provides health care regulatory due diligence advice on buy-side and sell-side transactions for a wide range of providers and suppliers.
  • Acted as a Legal IRO for a hospital’s OIG CIA for five years.

Awards and Recognition

  • Peer review rated as AV Preeminent®, the highest performance rating in Martindale-Hubbell® Peer Review Ratings™ system
  • Selected by her peers for inclusion in The Best Lawyers in America© in the field of Health Care Law (2018 – 2024)
  • Named the Best Lawyers® Health Care Law “Lawyer of the Year” in Jacksonville (2022, 2024)
  • Voted by her peers and selected as a member of Florida Trend’s Florida Legal Elite™ group (2020)

Affiliations

  • Hope Haven (board of directors)
  • Member, American Health Lawyers Association
  • Member, Health and Business Law Sections of the American Bar Association
  • Member, District of Columbia Bar Association and the Florida Bar Association

Presentations and Publications

18 September 2024 Health Care Law Today

Medicare Advantage: A Circuit Court Addresses What is (or is not) Material in False Claims Act Cases

On September 13, 2024, the United States Court of Appeals for the Eighth Circuit’s published its much-anticipated decision in United States ex rel. Holt v. Medicare Medicaid Advisors, affirming the Western District of Missouri’s dismissal of a Medicare Advantage case — a win for managed care stakeholders, especially insurance carriers, insurance brokers, and insurance marketing organizations.
04 September 2024 Health Care Law Today

Episode 34: “Let’s Talk Compliance”: Health Care Organizations Take Note: Trends and Pitfalls in the Bond Market Compliance Space

In this episode, partner Jana Kolarik of Foley’s Health Care Practice Group and PYA principal Angie Caldwell host Heidi Jeffery, a partner in Foley’s Finance and Financial Institutions Practice Group and Matt Stuart, a Principal in PYA’s Audit Assurance Service Line, discuss the latest trends in the bond market and the bond compliance pitfalls that organizations should avoid.
12 August 2024 Health Care Law Today

Compliance Compass: The Erlanger Complaint – A Cautionary Reminder About the Importance of FMV

Although most health care lawyers and compliance officers who review and analyze physician compensation understand that fair market value (FMV) is important, the nuances around FMV are sometimes missed.
22 July 2024 Health Care Law Today

Episode 33: Let’s Talk Compliance: What the July 3rd Ruling on FTC Non-Compete Ban Means for the Health Care Industry

In this episode, Benjamin Dryden, vice chair of Foley’s Antitrust & Competition Practice Group and David McMillan, managing principal of consulting and chief financial officer at PYA, discuss the recent July 3rd ruling on the U.S. Federal Trade Commission’s Non-compete Ban and how this will affect the health care & life sciences industry.
01 July 2024 Health Care Law Today

Episode 32: Let’s Talk Compliance: What the FTC’s Ban on Non-Competes Means for the Health Care Industry

In this episode, Benjamin Dryden, vice chair of Foley’s Antitrust & Competition Practice Group and David McMillan, managing principal of consulting and chief financial officer at PYA, discuss the FTC’s most recent decision to ban non-competes and how this ban will affect the health care & life sciences industry.
01 May 2024 In the News

Jana Kolarik on Health Care Compliance, AI

Foley & Lardner LLP partner Jana Kolarik emphasizes the importance of staying on top of recent changes in rules and enforcement priorities in the Relias Media article, "Compliance Requirements Continue to Change, Need Close Attention."